EnMotion, Embryo's Natural Motion

Not Applicable

Completed

• Conditions: Infertility
• Interventions: Other: Dynamic culture platform

• Registration Number: NCT02467725
• Lead Sponsor: Reproductive Medicine Associates of New Jersey

Brief Summary

The purpose of the study is to determine if a dynamic embryo microenvironment impacts embryo development and reproductive potential in comparison to static culture.

Detailed Description

The proposed research design is a prospective randomized control trial. Patients with normal ovarian reserve, who would be expected to have reasonable outcomes after in vitro fertilization, will serve as the subjects. Embryos from the same patient will be randomized to either static or dynamic culture. They will then be cultured to the blastocyst stage of embryo development and biopsied for preimplantation genetic screening. The best chromosomally normal embryo from each culture group will be selected and transferred to complete a double embryo transfer in a subsequent frozen embryo transfer cycle the following month.

Study Timeline

• Study First Submitted: 2015-06-03
• Study Start: 2015-06-09
• Study First Submitted QC: 2015-06-09
• Study First Posted: 2015-06-10
• Primary Completion: 2018-05-31
• Study Completion: 2018-10-15
• Status Verified: 2019-04
• Last Update Submitted: 2019-04-03
• Last Update Posted: 2019-04-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

• Infertile women seeking in vitro fertilization treatment with aneuploidy screening
• Patient is eligible for a two-embryo transfer in compliance with ASRM guidelines
• Patient able to undergo a frozen embryo transfer cycle the month following the vaginal oocyte retrieval procedure
• Maximum day 3 Follicle-stimulating hormone level (≤12 IU/L)
• Anti-mullerian hormone level ≥ 1.2g/mL, tested within previous year
• ≤1 prior failed IVF cycle
• Male partner with >100,000 total motile spermatozoa per ejaculate (donor sperm acceptable)
• Body Mass Index ≤ 32
• Antral Follicle Count ≥ 8

Exclusion Criteria

• Diagnosis of endometrial insufficiency defined as a prior cycle with maximal endometrial thickness ≤ 6mm, abnormal endometrial pattern (failure to attain a trilaminar appearance), persistent endometrial fluid
• Use of oocyte donation
• Use of gestational carrier
• Medical contraindication to double embryo transfer
• Use of testicular aspiration or biopsy procedures to obtain sperm
• Presence of a hydrosalpinx that communicates with the endometrial cavity
• Any contraindications to undergoing in vitro fertilization or gonadotropin stimulation
• Single gene disorder requiring more detailed embryo genetic analysis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Dynamic Culture Platform	Dynamic culture platform	Embryos randomized to the dynamic arm will be placed on the NSSB-300 microvibration platform within the designated incubator. The platform will vibrate at a strength setting of 4 for 5 seconds every 60 minutes. The embryos will be placed on the platform at the two pronucleur stage of development and remain on the platform until the blastocyst stage of development at which time the embryos will be biopsied for preimplantation genetic screening and frozen.

Primary Outcome Measures

Name	Time	Method
Blastulation Rate	6 days post vaginal oocyte retrieval procedure	the number of blastocysts will be counted

Secondary Outcome Measures

Name	Time	Method
Clinical Pregnancy Rate	approximately 20-25 days post embryo transfer procedure	documented intrauterine pregnancy

Trial Locations

Locations (1)

Reproductive Medicine Associates of New Jersey; 🇺🇸 Basking Ridge, New Jersey, United States